Martin Hemmerling
BioPharmaceuticals R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Topical BET PROTACs for locally restricted protein degradation in the lung.
Journal: RSC medicinal chemistry
Published: February 24, 2025
New ionizable lipids for non-viral mRNA delivery with secondary amine cyclic ether head groups.
Journal: RSC medicinal chemistry
Published: February 05, 2025
Precise and systematic end group chemistry modifications on PAMAM and poly(l-lysine) dendrimers to improve cytosolic delivery of mRNA.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 15, 2022
Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: September 13, 2022
New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Journal: European journal of pharmacology
Published: January 15, 2021
Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.
Journal: Journal of medicinal chemistry
Published: September 23, 2017
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.
Journal: Bioorganic & medicinal chemistry letters
Published: August 12, 2016
Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: November 02, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026